Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

7 Tools to Identify Depression

Nancy Sharby, PT, DPT, MS  |  Issue: August 2014  |  August 1, 2014

In addition, a yes to Question 9, which asks about thoughts of self-harm and/or suicide, is also diagnostic.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Depression is a frequent occurrence among those with chronic health issues.

Depression is a frequent occurrence among those with chronic health issues.

The healthcare provider is instructed to follow up the checklist with an interview to verify the answers and to place the answers in context. Studies have demonstrated that a cut-off score of 10 or higher yields a sensitivity of 88% and a specificity of 88% for major depression.28 Of the nine items on the scale, three (energy, eating and sleep) are also present in people who have arthritis, which can make it problematic for use in this population.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

A scaled down version of the PHQ-9 is the PHQ-2. This shorter version contains only two questions that are effective for performing a screen without rating the severity of the depression. It’s appropriate for use in a busy practice in which the provider must screen for and collect information about many health-related conditions.29 In the PHQ-2, the two relevent questions ask for the frequency of two symptoms over the past week. They are having a depressed mood and loss of interest in activities. The possible scores run from 0–6. A cut-off score of 3 or greater yielded a sensitivity of 83% and a specificity of 92%. Further, as the scores increase, difficulty performing important life activities, such as going to work and healthcare use, increase.29 This two-question tool is as effective as longer screens and does not contain any questions that overlap with the symptoms of arthritis.

The PRIME-MD is another frequently used, validated tool to measure depression. It consists of 27 questions (see Table 3). However, it has been reported that a “yes” answer to one of two critical questions had 86% sensitivity and 75% specificity, compared with a subsequent telephone interview diagnosis of MDD.30

Health professionals should include screening for depression so as to improve treatment adherence, patient quality of life and clinical outcomes, including pain, fatigue & poor sleep.

Whooley et al carried out a study of 536 patients attending a VA hospital to determine the efficacy of using these two questions with a simultaneous interview to determine the sensitivity and specificity of the tool. Another goal of this study was to determine the validity of these two critical questions compared with six previously validated screens.

The two questions were selected because they asked for the essential features of MDD (depressed mood and loss of interest in activities), which occurred over a period of at least two weeks. The two questions selected from the PRIME-MD questionnaire are: 1) “During the past two weeks, have you often been bothered by feeling down, depressed or hopeless?” and 2) “During the past two weeks, have you often been bothered by having little interest or pleasure in doing things?”30

Page: 1 2 3 4 5 6 7 8 9 10 | Single Page
Share: 

Filed under:Career DevelopmentConditionsEducation & TrainingOsteoarthritis and Bone DisordersProfessional TopicsResearch RheumRheumatoid ArthritisVasculitis Tagged with:Association of Rheumatology Professionals (ARP)DepressionOsteoarthritispatient carepsychological disorderResearchRheumatoid arthritisscreeningsymptom

Related Articles

    Depression in Rheumatoid Arthritis

    November 1, 2012

    Examining the psychological and health-related comorbidities of rheumatoid arthritis patients with depression

    Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease

    December 1, 2014

    A review of data on antinuclear antibodies and tests for rheumatoid arthritis

    Study Examines How Depression Subtypes May Stem from Osteoarthritis

    October 18, 2019

    People with or at risk for sympto­matic knee osteoarthritis (OA) may be assigned to four depression subtypes with distinct clusters of depressive symptoms that may affect pain and disability over time, according to a new study in Arthritis Care & Research.1 Four depression subtypes were identified in the study using the Center for Epidemiologic Studies…

    Tips for Treating Pain, Depression in Patients with Rheumatic Disease Offered at the ACR/ARHP’s 2013 Annual Meeting

    April 2, 2014

    Observational pain scales, diagnostic tools, pharmacologic interventions, and support from psychologists, caregivers recommended

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences